Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.740
+0.110 (6.75%)
At close: Mar 9, 2026, 4:00 PM EDT
1.730
-0.010 (-0.58%)
After-hours: Mar 9, 2026, 6:11 PM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $259.27 million as of March 9, 2026. Its market cap has increased by 9,464.67% in one year.
Market Cap
259.27M
Enterprise Value
248.29M
1-Year Change
9,464.67%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $259.27M, an increase of 245.37%. That is a compound annual growth rate of 29.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 242.88M | -30.64% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prelude Therapeutics | 267.79M |
| Cellectis | 265.08M |
| Ovid Therapeutics | 264.27M |
| Context Therapeutics | 264.15M |
| Cybin | 262.19M |
| Orchestra BioMed Holdings | 254.09M |
| Inhibikase Therapeutics | 251.68M |
| Fennec Pharmaceuticals | 250.17M |